Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Plus Therapeutics Inc PSTV

Healthcare Biotechnology
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers. The Company combines image-guided local beta radiation and targeted drug delivery approaches. The Company is advancing a pipeline of product candidates with lead programs in recurrent glioblastoma... see more

Recent & Breaking News (NDAQ:PSTV)

Cytori Receives Key Cell Therapy Patent for Scleroderma

GlobeNewswire July 6, 2017

Today's Research Report Coverage on Biotech Stocks -- Cyclacel Pharma, Cytori Therapeutics, La Jolla Pharma, and Moleculin Biotech

PR Newswire June 19, 2017

Cytori® Partners with myTomorrows for Managed Access Program for Europe, Middle East and Latin America

GlobeNewswire June 14, 2017

Long Term Safety Data Published on Cytori Technology for Breast Reconstruction After Oncologic Surgery & Radiation Therapy

GlobeNewswire June 8, 2017

Cytori to Introduce Next-Generation Celution® Technology

GlobeNewswire June 1, 2017

Cytori and BARDA Execute $13.4 Million Contract Option for Burn Clinical Trial

GlobeNewswire May 31, 2017

Cytori Logs Final 48 Week Patient Follow Up Visit in Scleroderma Trial

GlobeNewswire May 23, 2017

22 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  May 19, 2017

25 Stocks Moving In Thursday's Pre-Market Session

Benzinga.com  May 18, 2017

Cytori Provides Latest Corporate Update at the 18th Annual B. Riley & Co. Institutional Investor Conference

GlobeNewswire May 16, 2017

Cytori Reports First Quarter 2017 Business and Financial Results

GlobeNewswire May 11, 2017

One Year Follow Up of Cytori Cell Therapy™ in Investigator Erectile Dysfunction Trial

GlobeNewswire May 10, 2017

Cytori Therapeutics Announces Inducement Grants for New Employees

GlobeNewswire May 5, 2017

Cytori to Webcast First Quarter Financial Results on May 11

GlobeNewswire April 27, 2017

11 Biggest Mid-Day Losers For Tuesday

Benzinga.com  April 11, 2017

Cytori Announces Pricing of $9.5M Public Offering of Common Stock

GlobeNewswire April 11, 2017

Cytori Announces Proposed Public Offering of Common Stock

GlobeNewswire April 10, 2017

14 Biggest Mid-Day Gainers For Monday

Benzinga.com  April 10, 2017

Cytori Receives U.S. FDA Approval for Burn Clinical Trial Related to BARDA Contract

GlobeNewswire April 10, 2017

Cytori Appoints Gregg Lapointe to Board of Directors

GlobeNewswire April 3, 2017